| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0025-7125(02)00008-1 |
| P698 | PubMed publication ID | 12168556 |
| P2093 | author name string | Gustavo C Román | |
| P2860 | cites work | Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke : Gathering the Evidence | Q22306359 |
| “Mini-mental state” | Q25938989 | ||
| Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia | Q52033282 | ||
| A 24-month, double-blind, placebo-controlled multicentre pilot study of the efficacy and safety of nicergoline 60 mg per day in elderly hypertensive patients with leukoaraiosis | Q52034400 | ||
| Pentoxifylline in cerebrovascular dementia | Q52077937 | ||
| Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study | Q53243175 | ||
| Untangling vascular dementia | Q53246011 | ||
| Neurotransmitter deficits in a non-multi-infarct category of vascular dementia | Q53300658 | ||
| Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia | Q53324155 | ||
| Summary of the proceedings of the First International Workshop on CADASIL. Paris, May 19-21, 1993. | Q53384692 | ||
| Leuko-Araiosis | Q56005418 | ||
| Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | Q56502592 | ||
| Reliabilities, Norms and Factor Structure of the Behavioral Dyscontrol Scale | Q57310575 | ||
| Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study | Q57782154 | ||
| The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings | Q57782178 | ||
| Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline | Q57830693 | ||
| An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors | Q58748656 | ||
| Clinical determinants of dememtia related to stroke | Q61881963 | ||
| 15-year longitudinal study of blood pressure and dementia | Q71021081 | ||
| A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia | Q71978842 | ||
| Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer's type: adverse effects on cerebromicrovascular system | Q73924775 | ||
| The incidence of vascular dementia in Canada: a comparison with Europe and East Asia | Q74322111 | ||
| Hypertension and dementia | Q77323577 | ||
| Prevention of stroke in patients with nonvalvular atrial fibrillation | Q77332428 | ||
| The phenotypic spectrum of CADASIL: clinical findings in 102 cases | Q77568574 | ||
| Anterior choroidal artery infarction presenting as a progressive cognitive deficit | Q52028722 | ||
| Antiplatelet Agents for Secondary Prevention of Ischemic Stroke | Q28190669 | ||
| Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients | Q28255796 | ||
| Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12 | Q28268718 | ||
| Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators | Q28288542 | ||
| Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 | ||
| Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule | Q30662720 | ||
| Systemic amyloid deposits in familial British dementia. | Q30718374 | ||
| Thalamocortical diaschisis: positron emission tomography in humans | Q33591762 | ||
| Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities | Q33731244 | ||
| A historical review of the concept of vascular dementia: lessons from the past for the future | Q33803105 | ||
| Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. | Q33908676 | ||
| Alzheimer's disease and vascular dementia. Some points of confluence | Q33922757 | ||
| Prefrontal neurons in networks of executive memory | Q33988860 | ||
| Executive frontal functions | Q33995910 | ||
| Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury | Q34079614 | ||
| Neuropathologic substrates of ischemic vascular dementia | Q34088144 | ||
| Current Concepts in Mild Cognitive Impairment | Q34104314 | ||
| Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis | Q34106491 | ||
| Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension | Q34140282 | ||
| Oxiracetam in dementia: a double-blind, placebo-controlled study | Q34256854 | ||
| Amnesia after anterior communicating artery aneurysm rupture | Q34263124 | ||
| Frontal-subcortical circuits and human behavior | Q34352930 | ||
| The cerebellar cognitive affective syndrome | Q34467220 | ||
| Statins and neuroprotection | Q34481771 | ||
| Statins and the risk of dementia | Q34511970 | ||
| Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo | Q34514599 | ||
| MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease | Q35775989 | ||
| Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations | Q36482713 | ||
| Low blood pressure and dementia in elderly people: the Kungsholmen project | Q36598015 | ||
| Binswanger's disease--revisited | Q36701099 | ||
| Caudate infarcts | Q38140837 | ||
| Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings | Q39238753 | ||
| Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type | Q39264360 | ||
| The prevalence of dementia: a quantitative integration of the literature | Q39692741 | ||
| Frontal-subcortical circuits and neuropsychiatric disorders | Q40582849 | ||
| Pentoxifylline | Q40740262 | ||
| Dementia as a predictor of adverse outcomes following stroke: an evaluation of diagnostic methods | Q40871810 | ||
| Anatomic and behavioral aspects of frontal-subcortical circuits | Q40965766 | ||
| Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders | Q41035775 | ||
| Cranial computed tomographic observations in multi-infarct dementia. A controlled study | Q41116243 | ||
| Is vascular dementia really Alzheimer's disease or mixed dementia? | Q41225706 | ||
| The identity of lacunar dementia and Binswanger disease | Q41500281 | ||
| Frontal-subcortical circuits: the anatomic basis of executive, social and motivated behaviors | Q41518697 | ||
| Cerebral Microvascular Alterations in Aging, Leukoaraiosis, and Alzheimer's Diseasea | Q41611048 | ||
| The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons | Q41678964 | ||
| Status of Risk Factors for Vascular Dementia | Q41741782 | ||
| Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. | Q43615574 | ||
| Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up | Q43650940 | ||
| Cholesterol and Alzheimer's disease: is there a link? | Q43747009 | ||
| Hyperhomocysteinemia in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). | Q43836523 | ||
| New approaches to clinical trials in vascular dementia: memantine in small vessel disease | Q43922061 | ||
| Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial | Q43966701 | ||
| Medullary arteries in aging and dementia | Q44347066 | ||
| Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors | Q44608028 | ||
| Decreased cerebral blood flow precedes multi-infarct dementia, but follows senile dementia of Alzheimer type | Q44872182 | ||
| The incidence of dementia: a meta-analysis | Q45174488 | ||
| Clinical-neuropathological correlations in Alzheimer's disease and related dementias | Q46927555 | ||
| Senile dementia of the Binswanger type. A vascular form of dementia in the elderly | Q48195801 | ||
| Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series | Q48212849 | ||
| Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
| Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial | Q48359732 | ||
| Why do frontal lobe symptoms predominate in vascular dementia with lacunes? | Q48368845 | ||
| CADASIL in a North American family: clinical, pathologic, and radiologic findings | Q48390442 | ||
| Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? | Q48425564 | ||
| Multi-infarct dementia. A cause of mental deterioration in the elderly | Q48537830 | ||
| A quantitative MRI study of vascular dementia | Q48553449 | ||
| Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome | Q48575979 | ||
| Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias | Q48613775 | ||
| Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy | Q48642657 | ||
| On the history of lacunes, etat criblé, and the white matter lesions of vascular dementia | Q48657402 | ||
| Hypotension and cognitive impairment: Selective association in patients with heart failure | Q48692145 | ||
| Cognitive impairment in congestive heart failure?: Embolism vs hypoperfusion | Q48692172 | ||
| Subcortical dementia associated with striking enlargement of the Virchow-Robin spaces and transneural degeneration of the left mammillo-thalamic tract | Q48705197 | ||
| New insight into Binswanger disease | Q48744228 | ||
| Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces | Q48744839 | ||
| Poststroke dementia: incidence and relationship to prestroke cognitive decline | Q48760465 | ||
| Angular gyrus syndrome simulating Alzheimer's disease | Q48889719 | ||
| Observations on the brains of demented old people | Q48896308 | ||
| Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types. | Q48944538 | ||
| Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study | Q48958955 | ||
| From UBOs to Binswanger's disease. Impact of magnetic resonance imaging on vascular dementia research | Q48958963 | ||
| Frontal systems impairment following multiple lacunar infarcts | Q49115480 | ||
| Cortical blood vessels of the human brain | Q49161720 | ||
| Stroke, disability, and dementia: results of a population survey | Q50970204 | ||
| Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). | Q51976090 | ||
| Clock drawing is sensitive to executive control: a comparison of six methods | Q51980487 | ||
| The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease | Q51989567 | ||
| Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort | Q52002662 | ||
| Perspectives in the treatment of vascular dementia | Q52006847 | ||
| Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial | Q52026782 | ||
| P433 | issue | 3 | |
| P921 | main subject | dementia | Q83030 |
| prevention | Q1717246 | ||
| pathogenesis | Q372016 | ||
| vascular dementia | Q583908 | ||
| P304 | page(s) | 477-499 | |
| P577 | publication date | 2002-05-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Medical Clinics of North America | Q15761972 |
| P1476 | title | Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention | |
| P478 | volume | 86 |
| Q27334259 | (-)-SCR1693 Protects against Memory Impairment and Hippocampal Damage in a Chronic Cerebral Hypoperfusion Rat Model |
| Q35589311 | Acupuncture attenuates cognitive deficits and increases pyramidal neuron number in hippocampal CA1 area of vascular dementia rats |
| Q38779069 | Animal Models of Vascular Cognitive Impairment and Dementia (VCID). |
| Q44492251 | ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis |
| Q53096507 | Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: A meta-analysis |
| Q35950457 | Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study |
| Q37346589 | Association of ACE I/D gene polymorphism with vascular dementia: a meta-analysis |
| Q34921939 | Biphasic Functional Regulation in Hippocampus of Rat with Chronic Cerebral Hypoperfusion Induced by Permanent Occlusion of Bilateral Common Carotid Artery |
| Q35841696 | Brain hypoperfusion: a critical factor in vascular dementia |
| Q24203932 | Buflomedil for acute ischaemic stroke |
| Q45086731 | Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). |
| Q24201712 | Cerebrolysin for vascular dementia |
| Q24235891 | Cerebrolysin for vascular dementia |
| Q37570868 | Chronic cerebral hypoperfusion causes decrease of O-GlcNAcylation, hyperphosphorylation of tau and behavioral deficits in mice |
| Q37224541 | Cognitive impairment after cerebrovascular stroke: Relationship to vascular risk factors |
| Q35489232 | Cognitive performance after first ever stroke related to progression of vascular brain damage: a 2 year follow up CT scan study |
| Q24567980 | Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome |
| Q36249979 | Dementia with cerebrovascular disease: the benefits of early treatment |
| Q37154465 | Differences in rate of functional decline across three dementia types |
| Q33188549 | Diffusion MRI studies in vascular cognitive impairment and dementia |
| Q46726995 | Donepezil in vascular dementia: combined analysis of two large-scale clinical trials |
| Q33150809 | Donepezil: a clinical review of current and emerging indications |
| Q35598667 | Donepezil: in vascular dementia |
| Q42936632 | EEG Spectral Features Discriminate between Alzheimer's and Vascular Dementia |
| Q47152086 | EXIT25 - Executive interview applied to a cognitively healthy elderly population with heterogeneous educational background |
| Q45891454 | Effect of electroacupuncture on the expression of mTOR and eIF4E in hippocampus of rats with vascular dementia |
| Q26998916 | Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a review |
| Q58805390 | Effects of repetitive transcranial magnetic stimulation on cognitive function and cholinergic activity in the rat hippocampus after vascular dementia |
| Q42065361 | Environmental Enrichment Improves Spatial Learning and Memory in Vascular Dementia Rats with Activation of Wnt/β-Catenin Signal Pathway. |
| Q38263473 | From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration |
| Q38219438 | Heartsick: psychiatric and inflammatory implications of cerebromicrovascular disease |
| Q89619974 | Histamine H3 Receptor Antagonist Enhances Neurogenesis and Improves Chronic Cerebral Hypoperfusion-Induced Cognitive Impairments |
| Q37075664 | Hydrogen Sulfide Prevents Synaptic Plasticity from VD-Induced Damage via Akt/GSK-3β Pathway and Notch Signaling Pathway in Rats |
| Q47673598 | Hydrogen sulfide attenuates neuronal injury induced by vascular dementia via inhibiting apoptosis in rats |
| Q37337605 | Hypertension, brain damage and cognitive decline. |
| Q30586714 | Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation |
| Q36375702 | Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1 |
| Q53388305 | Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias |
| Q26825619 | N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease |
| Q26750515 | Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease |
| Q31078864 | Neuroradiological findings in vascular dementia |
| Q34288124 | Pharmacological prevention and treatment of vascular dementia: Approaches and perspectives |
| Q57821537 | Prevalence and factors associated with memory disturbance and dementia after acute ischemic stroke |
| Q37644408 | Protective Effect of 17β-Estradiol Upon Hippocampal Spine Density and Cognitive Function in an Animal Model of Vascular Dementia |
| Q34198750 | Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size |
| Q37452576 | Regularized Linear Discriminant Analysis of EEG Features in Dementia Patients |
| Q36153360 | Rivastigmine for subcortical vascular dementia |
| Q98289087 | Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial |
| Q49076465 | The neuropathology of vascular and mixed dementia and vascular cognitive impairment |
| Q47811906 | The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies |
| Q86822990 | Tongqiao Huoxue Decoction ameliorates learning and memory defects in rats with vascular dementia by up-regulating the Ca(2+)-CaMKII-CREB pathway |
| Q80349173 | Treatment of vascular dementia: evidence from epidemiologic studies |
| Q35581150 | Treatments for stroke |
| Q47964631 | Update on Vascular Dementia |
| Q35197111 | Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications |
| Q26820823 | Vascular aspects of cognitive impairment and dementia |
| Q36767965 | Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo |
| Q36331030 | Vascular dementia prevention: a risk factor analysis |
| Q37017429 | Vascular dementia: pharmacological treatment approaches and perspectives |
Search more.